应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TARS Tarsus Pharmaceuticals, Inc.
交易中 11-26 12:57:07 EST
50.48
+2.16
+4.46%
最高
50.74
最低
48.06
成交量
24.65万
今开
48.35
昨收
48.32
日振幅
5.55%
总市值
19.30亿
流通市值
14.64亿
总股本
3,823万
成交额
1,215万
换手率
0.85%
流通股本
2,901万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Tarsus Pharmaceuticals, Inc.2024财年第三财季实现净利润-23.42百万美元,同比增加40.18%
市场透视 · 11-23
Tarsus Pharmaceuticals, Inc.2024财年第三财季实现净利润-23.42百万美元,同比增加40.18%
Tarsus Pharmaceuticals, Inc.盘中异动 快速拉升5.03%报46.88美元
市场透视 · 11-20
Tarsus Pharmaceuticals, Inc.盘中异动 快速拉升5.03%报46.88美元
美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals
路透中文 · 11-18
美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals
Tarsus Pharmaceuticals, Inc.盘中异动 股价大涨9.67%
市场透视 · 11-14
Tarsus Pharmaceuticals, Inc.盘中异动 股价大涨9.67%
Tarsus Pharmaceuticals Inc 预计每股亏损 94 美分 - 财报前瞻
路透中文 · 11-12
Tarsus Pharmaceuticals Inc 预计每股亏损 94 美分 - 财报前瞻
Tarsus Pharmaceuticals, Inc.盘中异动 急速拉升5.13%报49.19美元
市场透视 · 11-09
Tarsus Pharmaceuticals, Inc.盘中异动 急速拉升5.13%报49.19美元
Tarsus Pharmaceuticals, Inc.盘中异动 急速拉升5.06%报47.97美元
市场透视 · 11-06
Tarsus Pharmaceuticals, Inc.盘中异动 急速拉升5.06%报47.97美元
Tarsus Pharmaceuticals, Inc.盘中异动 快速拉升5.37%
市场透视 · 11-01
Tarsus Pharmaceuticals, Inc.盘中异动 快速拉升5.37%
Tarsus Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.04%
市场透视 · 10-30
Tarsus Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.04%
Tarsus Pharmaceuticals, Inc.盘中异动 下午盘大幅上涨5.02%报38.28美元
市场透视 · 10-23
Tarsus Pharmaceuticals, Inc.盘中异动 下午盘大幅上涨5.02%报38.28美元
Tarsus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.05%报33.90美元
市场透视 · 10-04
Tarsus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.05%报33.90美元
Tarsus Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.01%报31.49美元
市场透视 · 09-27
Tarsus Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.01%报31.49美元
Tarsus Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.07%报34.20美元
市场透视 · 09-19
Tarsus Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.07%报34.20美元
Tarsus Pharmaceuticals, Inc.2024财年第二财季实现净利润-33.29百万美元,同比减少5.95%
自选股智能写手 · 08-18
Tarsus Pharmaceuticals, Inc.2024财年第二财季实现净利润-33.29百万美元,同比减少5.95%
Tarsus Pharmaceuticals, Inc.盘中异动 大幅跳水5.38%
自选股智能写手 · 08-16
Tarsus Pharmaceuticals, Inc.盘中异动 大幅跳水5.38%
Tarsus Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.53%
自选股智能写手 · 08-13
Tarsus Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.53%
Tarsus Pharmaceuticals, Inc.盘中异动 下午盘快速下跌5.25%报25.44美元
自选股智能写手 · 08-13
Tarsus Pharmaceuticals, Inc.盘中异动 下午盘快速下跌5.25%报25.44美元
Tarsus Pharmaceuticals, Inc.股价飙升15.80% 市值涨1.64亿美元
自选股智能写手 · 08-09
Tarsus Pharmaceuticals, Inc.股价飙升15.80% 市值涨1.64亿美元
Tarsus Pharmaceuticals Inc 预计每股亏损92美分 - 财报前瞻
Reuters · 08-07
Tarsus Pharmaceuticals Inc 预计每股亏损92美分 - 财报前瞻
Tarsus Pharmaceuticals, Inc.盘中异动 大幅跳水5.21%报22.21美元
自选股智能写手 · 08-02
Tarsus Pharmaceuticals, Inc.盘中异动 大幅跳水5.21%报22.21美元
加载更多
公司概况
公司名称:
Tarsus Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Tarsus Pharmaceuticals, Inc.是根据特拉华州法律于2016年11月成立的公司。该公司是一家处于临床后期的生物制药公司,致力于治疗性候选药物的开发和商业化,以解决最初存在眼科疾病的巨大市场机遇有限的治疗选择。该公司的主要产品候选产品TP-03是2b/3期的新型疗法,目前正在开发中,用于治疗由蠕形螨引起的眼睑炎,这被称为蠕形螨眼。
发行价格:
--
{"stockData":{"symbol":"TARS","market":"US","secType":"STK","nameCN":"Tarsus Pharmaceuticals, Inc.","latestPrice":50.475,"timestamp":1732643824891,"preClose":48.32,"halted":0,"volume":246529,"delay":0,"floatShares":29013379,"shares":38226929,"eps":-3.700971,"marketStatus":"交易中","marketStatusCode":2,"change":2.155,"latestTime":"11-26 12:57:07 EST","open":48.35,"high":50.74,"low":48.06,"amount":12149028.748867001,"amplitude":0.055464,"askPrice":50.57,"askSize":10,"bidPrice":50.42,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-3.700971,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732654800000},"adr":0,"listingDate":1602820800000,"adjPreClose":48.32,"preHourTrading":{"tag":"盘前","latestPrice":48.32,"preClose":48.32,"latestTime":"09:28 EST","volume":2088,"amount":99961.87665600001,"timestamp":1732631280088},"postHourTrading":{"tag":"盘后","latestPrice":48.32,"preClose":48.32,"latestTime":"18:04 EST","volume":22501,"amount":1087214.2678,"timestamp":1732575867681},"volumeRatio":0.985877,"impliedVol":1.0739,"impliedVolPercentile":0.834},"requestUrl":"/m/hq/s/TARS","defaultTab":"news","newsList":[{"id":"2485980082","title":"Tarsus Pharmaceuticals, Inc.2024财年第三财季实现净利润-23.42百万美元,同比增加40.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485980082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485980082?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:01","pubTimestamp":1732291263,"startTime":"0","endTime":"0","summary":"11月23日,Tarsus Pharmaceuticals, Inc.公布财报,公告显示公司2024财年第三财季净利润为-23.42百万美元,同比增加40.18%;其中营业收入为48.12百万美元,同比增加2473.26%,每股基本收益为-0.61美元。从资产负债表来看,Tarsus Pharmaceuticals, Inc.总负债1.39亿美元,其中短期债务631000.00美元,资产负债比为2.71,流动比率为0.06。机构评级:截至2024年11月23日,当前有8家机构对Tarsus Pharmaceuticals, Inc.目标价做出预测,其中目标均价为65.00美元,其中最低目标价为41.00美元,最高目标价为84.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000121a24e488f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000121a24e488f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS"],"gpt_icon":0},{"id":"2484903029","title":"Tarsus Pharmaceuticals, Inc.盘中异动 快速拉升5.03%报46.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484903029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484903029?lang=zh_cn&edition=full","pubTime":"2024-11-20 04:59","pubTimestamp":1732049942,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日04时59分,Tarsus Pharmaceuticals, Inc.股票出现波动,股价快速上涨5.03%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.61%。其相关个股中,Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Abpro Holdings Inc C/Wts 12/11/2029 、Exicure, Inc.涨幅较大,Syros Pharmaceuticals, Inc.、Tff Pharmaceuticals, Inc.、Exicure, Inc.较为活跃,换手率分别为1351.92%、859.00%、168.13%,振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ,振幅分别为91.10%、81.67%、78.21%。Tarsus Pharmaceuticals, Inc.公司简介:Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司,从眼部护理开始,专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112004590298e43961&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112004590298e43961&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2484661939","title":"美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2484661939","media":"路透中文","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484661939?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:15","pubTimestamp":1731914144,"startTime":"0","endTime":"0","summary":"美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals路透11月18日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括 Airbnb、Post Holdings 和 Syndax Pharmaceuticals。* Post Holdings Inc POST.N:摩根大通将目标价从125美元上调至135美元 * Syndax Pharmaceuticals Inc SNDX.O:杰富瑞将目标价从37美元上调至43美元 * Transmedics Group Inc TMDX.O:TD Cowen将目标价从175美元下调至120美元以下是路透周一报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nL4S3MP0GY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","LU0287142896.SGD","BK4503","HK0000306701.USD","LU0051755006.USD","LU0543330483.HKD","LU1105468828.SGD","SNDX","HBBD.SI","LU0251144936.SGD","EFXT","LU0348788117.USD","PCOR","LU1983260115.SGD","MBI","IE00BZ08YR35.GBP","LU0345776255.USD","LU1481107354.HKD","LU0293314216.USD","LU1688375341.USD","ADSK","LU1439103000.SGD","LU0516422440.USD","LU0737861772.HKD","LU2355687059.USD","BK1502","YELP","89988","CAPR","LU1196710864.SGD","PLD","TARS","09988","POST","ABNB","PGR","IE00BFMHRM44.USD","TMDX","LU1048588211.SGD","BK1521","LU0228367735.SGD","IE00B19Z9Z06.USD","LU0541502299.USD","LU0543330566.HKD","INO","KRRO","LU0898667661.SGD","LU1023057109.AUD","BABA","OVV"],"gpt_icon":1},{"id":"2483804221","title":"Tarsus Pharmaceuticals, Inc.盘中异动 股价大涨9.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483804221","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483804221?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:33","pubTimestamp":1731594786,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时33分,Tarsus Pharmaceuticals, Inc.股票出现波动,股价大幅拉升9.67%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com涨幅较大,Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃,换手率分别为1524.93%、20.49%、11.75%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Pds Biotechnology Corporation,振幅分别为50.00%、27.94%、22.14%。Tarsus Pharmaceuticals, Inc.公司简介:Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司,从眼部护理开始,专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422330695be2cc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422330695be2cc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2482714791","title":"Tarsus Pharmaceuticals Inc 预计每股亏损 94 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482714791","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482714791?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:50","pubTimestamp":1731383419,"startTime":"0","endTime":"0","summary":"Tarsus Pharmaceuticals Inc 预计每股亏损 94 美分 - 财报前瞻Tarsus Pharmaceuticals Inc TARS.OQ TARS.O预计将在11月13日公布截至2024年9月30日的季度收入报告。LSEG 分析师对 Tarsus Pharmaceuticals Inc 的平均预期是每股亏损 94 美分。华尔街对 Tarsus Pharmaceuticals Inc 的 12 个月目标价中位数为 61.50 美元,高于其最新收盘价 49.08 美元。11月12日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。如有任何其他问题或反馈,请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL4S3MJ0DO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARS"],"gpt_icon":0},{"id":"2482143816","title":"Tarsus Pharmaceuticals, Inc.盘中异动 急速拉升5.13%报49.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482143816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482143816?lang=zh_cn&edition=full","pubTime":"2024-11-09 01:41","pubTimestamp":1731087698,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日01时41分,Tarsus Pharmaceuticals, Inc.股票出现波动,股价快速上涨5.13%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.02%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029、Rigel Pharmaceuticals, Inc.涨幅较大,Elevai Labs, Inc.、Lipella Pharmaceuticals Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃,换手率分别为725.58%、69.35%、59.42%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为102.22%、87.00%、52.00%。Tarsus Pharmaceuticals, Inc.公司简介:Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司,从眼部护理开始,专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109014138abaea7b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109014138abaea7b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2481984014","title":"Tarsus Pharmaceuticals, Inc.盘中异动 急速拉升5.06%报47.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481984014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481984014?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:24","pubTimestamp":1730906683,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时24分,Tarsus Pharmaceuticals, Inc.股票出现波动,股价大幅上涨5.06%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.30%。其相关个股中,Sonnet Biotherapeutics Holdings, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大,Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃,换手率分别为1888.49%、191.34%、92.57%,振幅较大的相关个股有Polypid Ltd.、Sonnet Biotherapeutics Holdings, Inc.、Cardio Diagnostics Holdings Inc.,振幅分别为106.65%、73.16%、27.16%。Tarsus Pharmaceuticals, Inc.公司简介:Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司,从眼部护理开始,专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106232443971a4d2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106232443971a4d2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS","BK4007"],"gpt_icon":0},{"id":"2480833208","title":"Tarsus Pharmaceuticals, Inc.盘中异动 快速拉升5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480833208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480833208?lang=zh_cn&edition=full","pubTime":"2024-11-01 23:19","pubTimestamp":1730474353,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日23时19分,Tarsus Pharmaceuticals, Inc.股票出现异动,股价急速上涨5.37%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.26%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Athira Pharma, Inc.、Theriva Biologics, Inc.涨幅较大,Theriva Biologics, Inc.、Gri Bio, Inc.、Ensysce Biosciences, Inc.较为活跃,换手率分别为3350.91%、815.71%、708.48%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tc Biopharm Plc C/Wts 10/02/2028 、Immatics N V C/Wts 01/07/2025 ,振幅分别为122.67%、96.49%、60.77%。Tarsus Pharmaceuticals, Inc.公司简介:Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司,从眼部护理开始,专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101231914971a3e5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101231914971a3e5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2479230889","title":"Tarsus Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479230889","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479230889?lang=zh_cn&edition=full","pubTime":"2024-10-30 01:27","pubTimestamp":1730222874,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日01时27分,Tarsus Pharmaceuticals, Inc.股票出现波动,股价快速拉升5.04%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.31%。其相关个股中,Glycomimetics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Dermata Therapeutics Inc C/Wts 涨幅较大,Glycomimetics, Inc.、Lixte Biotechnology Holdings, Inc.、Novabay Pharmaceuticals, Inc.较为活跃,换手率分别为1369.58%、1354.13%、334.31%,振幅较大的相关个股有Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Dermata Therapeutics Inc C/Wts ,振幅分别为183.65%、88.24%、78.31%。Tarsus Pharmaceuticals, Inc.公司简介:Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司,从眼部护理开始,专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030012754971a2fc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030012754971a2fc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS","BK4007"],"gpt_icon":0},{"id":"2477366453","title":"Tarsus Pharmaceuticals, Inc.盘中异动 下午盘大幅上涨5.02%报38.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477366453","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477366453?lang=zh_cn&edition=full","pubTime":"2024-10-23 01:45","pubTimestamp":1729619100,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日01时45分,Tarsus Pharmaceuticals, Inc.股票出现异动,股价急速上涨5.02%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.08%。其相关个股中,Ensysce Biosciences, Inc.、Genprex, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大,Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm Plc较为活跃,换手率分别为5424.28%、4922.87%、2105.18%,振幅较大的相关个股有Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.,振幅分别为189.27%、101.99%、99.41%。Tarsus Pharmaceuticals, Inc.公司简介:Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司,从眼部护理开始,专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023014500ab6c46d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023014500ab6c46d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2472957024","title":"Tarsus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.05%报33.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472957024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472957024?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:42","pubTimestamp":1728049323,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时42分,Tarsus Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.05%。截至发稿,该股报33.90美元/股,成交量1.1474万股,换手率0.03%,振幅4.12%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。Tarsus Pharmaceuticals, Inc.公司简介:Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司,从眼部护理开始,专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004214203a1de4cb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004214203a1de4cb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS","BK4007"],"gpt_icon":0},{"id":"2470089645","title":"Tarsus Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.01%报31.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470089645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470089645?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:48","pubTimestamp":1727444902,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时48分,Tarsus Pharmaceuticals, Inc.股票出现波动,股价快速跳水5.01%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.41%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Onconetix, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大,Onconetix, Inc.、Seelos Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.较为活跃,换手率分别为2870.18%、81.61%、67.94%,振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Cue Biopharma, Inc.,振幅分别为95.75%、51.69%、26.27%。Tarsus Pharmaceuticals, Inc.公司简介:Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司,从眼部护理开始,专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927214822ab66835b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927214822ab66835b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS","BK4007"],"gpt_icon":0},{"id":"2468153508","title":"Tarsus Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.07%报34.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468153508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468153508?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:55","pubTimestamp":1726754116,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时55分,Tarsus Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.07%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.80%。其相关个股中,Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大,Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃,换手率分别为1946.60%、504.62%、90.64%,振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025,振幅分别为79.91%、62.03%、52.97%。Tarsus Pharmaceuticals, Inc.公司简介:Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司,从眼部护理开始,专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192155179719bdbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192155179719bdbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2460381739","title":"Tarsus Pharmaceuticals, Inc.2024财年第二财季实现净利润-33.29百万美元,同比减少5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460381739","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460381739?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:02","pubTimestamp":1723910531,"startTime":"0","endTime":"0","summary":"8月18日,Tarsus Pharmaceuticals, Inc.公布财报,公告显示公司2024财年第二财季净利润为-33.29百万美元,同比减少5.95%;其中营业收入为40.81百万美元,每股基本收益为-0.88美元。机构评级:截至2024年8月18日,当前有9家机构对Tarsus Pharmaceuticals, Inc.目标价做出预测,其中目标均价为59.22美元,其中最低目标价为36.00美元,最高目标价为75.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800033795a164f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800033795a164f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS"],"gpt_icon":0},{"id":"2459248521","title":"Tarsus Pharmaceuticals, Inc.盘中异动 大幅跳水5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459248521","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459248521?lang=zh_cn&edition=full","pubTime":"2024-08-16 22:24","pubTimestamp":1723818252,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日22时24分,Tarsus Pharmaceuticals, Inc.股票出现波动,股价急速下跌5.38%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.18%。其相关个股中,Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Geovax Labs, Inc.涨幅较大,Cingulate Inc.、Seelos Therapeutics, Inc.、Geovax Labs, Inc.较为活跃,换手率分别为4468.63%、1636.68%、347.44%,振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Geovax Labs, Inc.,振幅分别为100.53%、53.54%、51.34%。Tarsus Pharmaceuticals, Inc.公司简介:Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司,从眼部护理开始,专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816222412ab5e170b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816222412ab5e170b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2459902516","title":"Tarsus Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459902516","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459902516?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:46","pubTimestamp":1723556802,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时46分,Tarsus Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.53%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.54%。Tarsus Pharmaceuticals, Inc.公司简介:Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司,从眼部护理开始,专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321464398e34ddb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321464398e34ddb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2459668937","title":"Tarsus Pharmaceuticals, Inc.盘中异动 下午盘快速下跌5.25%报25.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459668937","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459668937?lang=zh_cn&edition=full","pubTime":"2024-08-13 02:02","pubTimestamp":1723485738,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日02时02分,Tarsus Pharmaceuticals, Inc.股票出现波动,股价快速下跌5.25%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.94%。其相关个股中,Revance Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Newamsterdam Pharma Co Nv C/Wts 涨幅较大,60 Degrees Pharmaceuticals, Inc.、Entero Therapeutics Inc.、Oragenics Inc.较为活跃,换手率分别为674.70%、649.22%、88.66%,振幅较大的相关个股有Entero Therapeutics Inc.、60 Degrees Pharmaceuticals, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ,振幅分别为117.04%、91.10%、53.94%。Tarsus Pharmaceuticals, Inc.公司简介:Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司,从眼部护理开始,专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813020218af97193e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813020218af97193e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS","BK4007"],"gpt_icon":0},{"id":"2458659661","title":"Tarsus Pharmaceuticals, Inc.股价飙升15.80% 市值涨1.64亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458659661","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458659661?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:31","pubTimestamp":1723210292,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时31分,Tarsus Pharmaceuticals, Inc.股票出现异动,股价快速拉升15.80%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.32%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Third Harmonic Bio, Inc.、Adma Biologics Inc涨幅较大,Conduit Pharmaceuticals Inc.、Cns Pharmaceuticals, Inc.、Entero Therapeutics Inc.较为活跃,换手率分别为32.39%、5.35%、4.90%,振幅较大的相关个股有Brainstorm Cell Therapeutics Inc.、Enliven Therapeutics, Inc.、Relmada Therapeutics, Inc.,振幅分别为10.21%、9.58%、9.57%。Tarsus Pharmaceuticals, Inc.公司简介:Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司,从眼部护理开始,专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408092131329f1dc141&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408092131329f1dc141&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TARS"],"gpt_icon":0},{"id":"2457835987","title":"Tarsus Pharmaceuticals Inc 预计每股亏损92美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457835987","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457835987?lang=zh_cn&edition=full","pubTime":"2024-08-07 09:12","pubTimestamp":1722993148,"startTime":"0","endTime":"0","summary":" * Tarsus Pharmaceuticals Inc 将于8月8日公布截至2024年6月30日的财报,预计季度收入将有所增长。* 根据LSEG的数据,8位分析师的平均预期显示,这家总部位于加利福尼亚州尔湾市的公司预计将实现营收3166.4万美元。* LSEG 分析师对 Tarsus Pharmaceuticals Inc 的平均预期是每股亏损 92 美分。* 华尔街对 Tarsus Pharmaceuticals Inc 的 12 个月目标价中位数为 61.00 美元,高于其最新收盘价 23.14 美元。8月7日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tarsus Pharmaceuticals Inc 预计每股亏损92美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARS"],"gpt_icon":0},{"id":"2456823872","title":"Tarsus Pharmaceuticals, Inc.盘中异动 大幅跳水5.21%报22.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456823872","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456823872?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:34","pubTimestamp":1722605693,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时34分,Tarsus Pharmaceuticals, Inc.股票出现异动,股价大幅跳水5.21%。Tarsus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.59%。其相关个股中,Exicure, Inc.、Dermata Therapeutics, Inc.、Os Therapies Incorporated涨幅较大,Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为363.26%、153.03%、22.11%,振幅较大的相关个股有Exicure, Inc.、Dermata Therapeutics, Inc.、Anew Medical Inc C/Wts 21/06/2029 ,振幅分别为33.34%、26.61%、17.87%。Tarsus Pharmaceuticals, Inc.公司简介:Tarsus Pharmaceuticals Inc是一家商业阶段的生物制药公司,从眼部护理开始,专注于治疗药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213454af95a61f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213454af95a61f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TARS","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tarsusrx.com","stockEarnings":[{"period":"1week","weight":0.0827},{"period":"1month","weight":0.2261},{"period":"3month","weight":0.7903},{"period":"6month","weight":0.3925},{"period":"1year","weight":1.7898},{"period":"ytd","weight":1.3862}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tarsus Pharmaceuticals, Inc.是根据特拉华州法律于2016年11月成立的公司。该公司是一家处于临床后期的生物制药公司,致力于治疗性候选药物的开发和商业化,以解决最初存在眼科疾病的巨大市场机遇有限的治疗选择。该公司的主要产品候选产品TP-03是2b/3期的新型疗法,目前正在开发中,用于治疗由蠕形螨引起的眼睑炎,这被称为蠕形螨眼。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.056097},{"month":2,"riseRate":0.25,"avgChangeRate":0.056479},{"month":3,"riseRate":0,"avgChangeRate":-0.098569},{"month":4,"riseRate":0.5,"avgChangeRate":0.023334},{"month":5,"riseRate":0.75,"avgChangeRate":0.001731},{"month":6,"riseRate":0.5,"avgChangeRate":-0.041248},{"month":7,"riseRate":0.5,"avgChangeRate":-0.020177},{"month":8,"riseRate":0.75,"avgChangeRate":0.027434},{"month":9,"riseRate":0.75,"avgChangeRate":0.038599},{"month":10,"riseRate":0.75,"avgChangeRate":0.129536},{"month":11,"riseRate":0.6,"avgChangeRate":0.060039},{"month":12,"riseRate":0.5,"avgChangeRate":0.163245}],"exchange":"NASDAQ","name":"Tarsus Pharmaceuticals, Inc.","nameEN":"Tarsus Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tarsus Pharmaceuticals, Inc.(TARS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tarsus Pharmaceuticals, Inc.(TARS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tarsus Pharmaceuticals, Inc.,TARS,Tarsus Pharmaceuticals, Inc.股票,Tarsus Pharmaceuticals, Inc.股票老虎,Tarsus Pharmaceuticals, Inc.股票老虎国际,Tarsus Pharmaceuticals, Inc.行情,Tarsus Pharmaceuticals, Inc.股票行情,Tarsus Pharmaceuticals, Inc.股价,Tarsus Pharmaceuticals, Inc.股市,Tarsus Pharmaceuticals, Inc.股票价格,Tarsus Pharmaceuticals, Inc.股票交易,Tarsus Pharmaceuticals, Inc.股票购买,Tarsus Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tarsus Pharmaceuticals, Inc.(TARS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tarsus Pharmaceuticals, Inc.(TARS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}